000 | 03780nam a22005775i 4500 | ||
---|---|---|---|
001 | 978-3-031-64021-6 | ||
003 | DE-He213 | ||
005 | 20250516160129.0 | ||
007 | cr nn 008mamaa | ||
008 | 240901s2024 sz | s |||| 0|eng d | ||
020 |
_a9783031640216 _9978-3-031-64021-6 |
||
050 | 4 | _aRS199.5 | |
072 | 7 |
_aTCB _2bicssc |
|
072 | 7 |
_aSCI010000 _2bisacsh |
|
072 | 7 |
_aTCB _2thema |
|
082 | 0 | 4 |
_a615.6 _223 |
245 | 1 | 0 |
_aPharmacoproteomics _h[electronic resource] : _bRecent Trends and Applications / _cedited by Seth K. Amponsah, Kwabena F. M. Opuni, Yashwant V. Pathak. |
250 | _a1st ed. 2024. | ||
264 | 1 |
_aCham : _bSpringer Nature Switzerland : _bImprint: Springer, _c2024. |
|
300 |
_aXVI, 471 p. 100 illus., 50 illus. in color. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
505 | 0 | _aOverview of pharmacoproteomics and its clinical applications -- Pharmacoproteomics and precision medicine -- Pharmacoproteomics and drug target discovery -- Analytical methods in pharmacoproteomics -- Bridging the gap between pharmacoproteomics and pharmacogenomics -- Analysis and interpretation of pharmacoproteomic data -- Pharmacoproteomics and sickle cell management -- Pharmacoproteomics and cancer management -- Pharmacoproteomics and neurological disease management -- Pharmacoproteomics and rheumatoid arthritis management -- Proteomics and management of multiple sclerosis -- Biomarker development against infections using proteomics -- Proteomics and COVID-19: recent trends -- Proteomics in the pharmaceutical industry: prospects and challenges -- Nanomaterials in proteomics -- Big data analytics in pharmacoproteomics -- Recent mass spectrometry technologies in pharmacoproteomics -- High throughput pre-clinical models and pharmacoproteomics. | |
520 | _aThis book gives an overview of pharmacoproteomics and its clinical applications, as well as the latest information on drug mechanisms at the proteome level, the relationship between proteomics and toxicity or resistance, and how proteomics aid in discovery of new drug targets. The book also highlights recent advances in analytical methods, analysis, and interpretation of pharmacoproteomic data. Pharmacoproteomics: Recent Trends and Applications is an ideal book for those working in pharmaceutical industries, as well as scientists, health care professionals, and researchers who work in the field of genomics, pharmacology, pharmacokinetics, toxicology, and pharmaceutical chemistry. | ||
541 |
_fUABC ; _cPerpetuidad |
||
650 | 0 | _aDrug delivery systems. | |
650 | 0 | _aProteins. | |
650 | 0 | _aPharmaceutical chemistry. | |
650 | 0 | _aCytology. | |
650 | 1 | 4 | _aDrug Delivery. |
650 | 2 | 4 | _aProteins. |
650 | 2 | 4 | _aPharmaceutics. |
650 | 2 | 4 | _aCell Biology. |
700 | 1 |
_aAmponsah, Seth K. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
700 | 1 |
_aOpuni, Kwabena F. M. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
700 | 1 |
_aPathak, Yashwant V. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
710 | 2 | _aSpringerLink (Online service) | |
773 | 0 | _tSpringer Nature eBook | |
776 | 0 | 8 |
_iPrinted edition: _z9783031640209 |
776 | 0 | 8 |
_iPrinted edition: _z9783031640223 |
776 | 0 | 8 |
_iPrinted edition: _z9783031640230 |
856 | 4 | 0 |
_zLibro electrónico _uhttp://libcon.rec.uabc.mx:2048/login?url=https://doi.org/10.1007/978-3-031-64021-6 |
912 | _aZDB-2-SBL | ||
912 | _aZDB-2-SXB | ||
942 | _cLIBRO_ELEC | ||
999 |
_c276218 _d276217 |